Martingale Asset Management »

Soleno Therapeutics shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Soleno Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 291.11M1.115M1.12M1.125M1.13M22k23k24k25k
Value ($)Share countHistorical SLNO position of Martingale Asset Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.1M 25k 44.95
2024-09-30 $1.1M 22k 50.49

More positions owned by Martingale Asset Management

Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Microsoft Corporation (MSFT)
Berkshire Hathaway (BRK.B)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Facebook Inc cl a (META)
Visa (V)
At&t (T)
Cisco Systems (CSCO)
UnitedHealth (UNH)
Costco Wholesale Corporation (COST)
MasterCard Incorporated (MA)
Exxon Mobil Corporation (XOM)

View all positions for Martingale Asset Management

Top funds holding Soleno Therapeutics

Vivo Capital
Henderson Group
Nantahala Capital Management
Adage Capital Partners GP
Susquehanna International
venBio Select Advisor
BlackRock
Vanguard Group
T. Rowe Price Associates
Perceptive Advisors
Carlyle
State Street Corporation
Citadel Advisors
Commodore Capital
Caption Management

View all funds holding Soleno Therapeutics